Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Novo Nordisks Indian patent on semaglutide expires in March, opening the door for the countrys vast generic drug industry to enter the market
"As use of this medication is extended and expanded for weight loss and other health advocacy, there is an opportunity to do much more, including product development, packaging, online and in-store merchandising, education, and promotion." Opportunities include: Merchandise dietary and nutritional support items near the pharmacy in drug and grocery, improving the shopping experience for consumers taking GLP-1s Understand that 91% of Millennials, 90% of Gen Z, and 64% of Gen X on GLP-1 medications are interested in packaged foods that support their weight loss goals, and they want messaging called out on the package Meet consumers where they are with product and health information, amplifying digital commerce programming Advance opportunities on retailer apps and websites to support these shoppers Acosta Group's "GLP-1 & The Weight Loss Revolution Shopper Insights Study" was conducted Feb
If administering your own medication doesnt appeal to you, dont worryGrace + Beauty has you covered
Tirzepatide is a prescription injectable GLP-1 medication used to support medical weight loss and metabolic health
US$ 22.72
US$ 24.99
US$ 26.33
US$ 25.67
US$ 23.31
US$ 22.45
US$ 27.53
US$ 25.38
